Market Research Logo

AmpliPhi Biosciences Corporation (APHB) - Financial and Strategic SWOT Analysis Review

AmpliPhi Biosciences Corporation (APHB) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AmpliPhi Biosciences Corporation (AmpliPhi) is a biopharmaceutical company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophag technology developed a pipeline of products for the treatment of various infections. AmpliPhi’s pipeline product portfolio includes AmpliPhage-001, AmpliPhage-002, and AmpliPhage-004. It has collaboratios with companies such as Cystic Fibrosis Foundation Therapeutics, Inc., Intrexon Corporation, the U.S. Army, The Royal Brompton Clinic, and the University of Leicester, to rapidly advance bacteriophage-based therapies. It also has its operational presence in the US, Slovenia and Australia. AmpliPhi is headquartered in Richmond, Virginia, the US.

AmpliPhi Biosciences Corporation Key Recent Developments

Aug 15, 2016: AmpliPhi Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Jun 02, 2016: AmpliPhi Biosciences to be Granted European Patent Covering the Use of Phage Therapy to Resensitize Bacterial Infections To Antibiotics
May 12, 2016: AmpliPhi Biosciences Reports First Quarter 2016 Financial Results and Provides Corporate Update
Mar 30, 2016: AmpliPhi Biosciences Reports Full-Year 2015 Financial Results
Feb 09, 2016: AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia to its Collaboration Partner, Westmead Institute

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
AmpliPhi Biosciences Corporation - Key Facts
AmpliPhi Biosciences Corporation - Key Employees
AmpliPhi Biosciences Corporation - Key Employee Biographies
AmpliPhi Biosciences Corporation - Major Products and Services
AmpliPhi Biosciences Corporation - Pharmaceutical Pipeline Products Data
AmpliPhi Biosciences Corporation, Pipeline Products by Therapy Area
AmpliPhi Biosciences Corporation, Pipeline Products by Development Phase
AmpliPhi Biosciences Corporation - History
AmpliPhi Biosciences Corporation - Company Statement
AmpliPhi Biosciences Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
AmpliPhi Biosciences Corporation - Business Description
AmpliPhi Biosciences Corporation - Corporate Strategy
AmpliPhi Biosciences Corporation - SWOT Analysis
SWOT Analysis - Overview
AmpliPhi Biosciences Corporation - Strengths
Strength - Established Partnership Network
Strength - Focused Research & Development Activities
Strength - Proprietary Bacteriophage Technology
AmpliPhi Biosciences Corporation - Weaknesses
Weakness - History of Operating Losses
Weakness - Lack of Marketed Products
AmpliPhi Biosciences Corporation - Opportunities
Opportunity - Market Potential: Cystic Fibrosis
Opportunity - Rise of Superbugs
Opportunity - Strategic Acquisition
AmpliPhi Biosciences Corporation - Threats
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
AmpliPhi Biosciences Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
AmpliPhi Biosciences Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 15, 2016: AmpliPhi Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Jun 02, 2016: AmpliPhi Biosciences to be Granted European Patent Covering the Use of Phage Therapy to Resensitize Bacterial Infections To Antibiotics
May 12, 2016: AmpliPhi Biosciences Reports First Quarter 2016 Financial Results and Provides Corporate Update
Mar 30, 2016: AmpliPhi Biosciences Reports Full-Year 2015 Financial Results
Feb 09, 2016: AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia to its Collaboration Partner, Westmead Institute
Jan 19, 2016: AmpliPhi Biosciences Announces Appointment of Steve R. Martin as Chief Financial Officer
Nov 10, 2015: AmpliPhi Announces Board Expansion with Appointment of Two Highly-Experienced Non-Executive Directors
Sep 02, 2015: AmpliPhi Biosciences Announces Appointment of Alexander Gaidamaka as Vice President of Chemistry, Manufacturing and Control
Aug 18, 2015: AmpliPhi Biosciences Announces Approval of Common Stock Listing on NYSE MKT
Aug 13, 2015: AmpliPhi Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AmpliPhi Biosciences Corporation, Key Facts
AmpliPhi Biosciences Corporation, Key Employees
AmpliPhi Biosciences Corporation, Key Employee Biographies
AmpliPhi Biosciences Corporation, Major Products and Services
AmpliPhi Biosciences Corporation, Number of Pipeline Products by Therapy Area
AmpliPhi Biosciences Corporation, Number of Pipeline Products by Development Stage
AmpliPhi Biosciences Corporation, Pipeline Products By Therapy Area and Development Phase
AmpliPhi Biosciences Corporation, History
AmpliPhi Biosciences Corporation, Other Locations
AmpliPhi Biosciences Corporation, Subsidiaries
AmpliPhi Biosciences Corporation, Key Competitors
AmpliPhi Biosciences Corporation, Ratios based on current share price
AmpliPhi Biosciences Corporation, Annual Ratios
AmpliPhi Biosciences Corporation, Interim Ratios
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
AmpliPhi Biosciences Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AmpliPhi Biosciences Corporation, Pipeline Products by Therapy Area
AmpliPhi Biosciences Corporation, Pipeline Products by Development Phase
AmpliPhi Biosciences Corporation, Performance Chart (2011 - 2015)
AmpliPhi Biosciences Corporation, Ratio Charts
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
AmpliPhi Biosciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report